Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Circulation. 2017 Mar 30;135(22):2119–2132. doi: 10.1161/CIRCULATIONAHA.117.027272

Figure 3. Multivariable-adjusted association between the number of abnormal test results and cardiovascular endpoints in MESA.

Figure 3

All comparisons are versus participants with a risk score=0. All models adjusted for age, sex, race, smoking status, diabetes, total cholesterol, HDL-cholesterol, systolic blood pressure and blood pressure medications, and statin medications. The global CVD and mortality models were additionally adjusted for serum creatinine, and the heart failure models were additional adjusted for body mass index and creatinine. CVD=cardiovascular disease; ASCVD=atherosclerotic CVD, CHD=coronary heart disease; CHF=congestive heart failure; CV=cardiovascular